Company Filing History:
2 out of 145 
2 out of 53 
Years Active: 2021-2022
Title: Innovations of Ignacio Munoz-Sanjuan
Introduction
Ignacio Munoz-Sanjuan is a notable inventor based in New York, NY (US). He has made significant contributions to the field of biotechnology, particularly in the modulation of gene expression related to Huntington's Disease. With a total of 2 patents, his work has the potential to impact the lives of many individuals affected by this neurodegenerative disorder.
Latest Patents
Munoz-Sanjuan's latest patents include "Zinc finger protein compositions for modulation of huntingtin (Htt)" and "Methods and compositions for treating Huntington's Disease." The first patent focuses on methods for modulating Htt gene expression and HTT protein levels. The second patent outlines innovative methods and compositions aimed at treating or preventing Huntington's Disease.
Career Highlights
Throughout his career, Ignacio Munoz-Sanjuan has worked with prominent organizations such as Sangamo Therapeutics, Inc. and Chdi Foundation, Inc. His expertise in biotechnology and gene therapy has positioned him as a key figure in the research community.
Collaborations
Some of his notable coworkers include Steven Froelich and H. Steve Zhang. Their collaborative efforts have contributed to advancing research in the field of Huntington's Disease.
Conclusion
Ignacio Munoz-Sanjuan's innovative work and patents reflect his commitment to addressing critical health challenges. His contributions to the understanding and treatment of Huntington's Disease are invaluable and highlight the importance of continued research in biotechnology.